Stock Events

MabCure 

$0
7
+$0+0% Thursday 19:18

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
500
Avg. Volume
561
Mkt Cap
78,109
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

31DecConfirmed
Q4 2009
Q1 2010
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
-0.18
-0.12
-0.06
-0
Expected EPS
N/A
Actual EPS
-0.1765

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBCI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Biotechnology
Health Technology
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Show more...
CEO
Employees
3
Country
US
ISIN
US5540941029

Listings